Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
- Catherine O’reilly
- , Susan Mills
- , Mary C. Rea
- , Aonghus Lavelle
- , Subrata Ghosh
- , Colin Hill
- , R. Paul Ross
Research output: Contribution to journal › Review article › peer-review